According to CytoDyn latest financial reports the cash on hand of CYDY is $2.54M, an decrease of -39.94% to 2022. At the end of 2022 company had $4.23M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $2.54M | -39.94% |
2022 | $4.23M | -87.53% |
2021 | $33.94M | 137.66% |
2020 | $14.28M | 446.59% |
2019 | $2.61M | - |